Abstract
Get full access to this article
View all access options for this article.
References
1.
McKendrick MW
,
Geddes AM
: Allopurinol hypersensitivity . Br Med J
1 :988 , 1979
2.
Jick H.
,
Porter JB
: Potentiation of ampicillin skin reactions by allopurinol or hyperuricemia . J Clin Pharmacol
21 :456 -458 , 1981
3.
McEvoy GK
: Drug Information 91. Bethesda, MD , ASHP
1991 , p 2242
4.
Product information
: Zyloprim brand of allopurinol . Burroughs Wellcome Company , Research Park, NC
5.
Arnold HL
,
Odom RB
,
James WD
: Andrew's Diseases of the Skin . Philadelphia, PA , Saunders , 1990 , pp 136 -137
6.
Ellman MH
,
Fretzin DF
,
Olson W.
: Toxic epidermal necrolysis associated with allopurinol administration . Arch Dermatol
111 :986 -990 , 1975
7.
Moschella SL
,
Hurley HJ
: Dermatology . Philadelphia, PA , Saunders , 1985 , pp 467 -471
8.
DiPiro JT
: Pharmacotherapy-A pathophysiologic Approach . New York, NY , Elsevier , 1989 , pp 976 -977
9.
Olin BR
: Facts and Comparisons . St Louis, MO , Lippincott , 1992 , 165e
10.
Product information
: Vasotec brand of enalapril . Merck Sharp & Dohme , West Point, PA
11.
Product information
: Capoten brand of captopril , E.R. Squibb and Sons, Inc. , Princeton, NJ
12.
Pennell DJ
,
Nunan TO
,
O'Doherty MJ
, et al: Fatal Stevens-Johnson syndrome in a patient on captopril and allopurinol . Lancet
1 :43 , 1984
13.
Samanta A.
,
Burden AC
: Fever, myalgia, and arthralgia in a patient on captopril and allopurinol . Lancet
1 :79 , 1984